🎓 Webcasts from our Summer School in Stockholm this June are now available on #myECTRIMS! Gain insights from leading experts on Visual System Evaluation in #MS and Other Demyelinating Diseases. Watch them here: https://t.co/ZZx9ZubXn0
#ECTRIMSNextGen#MultipleSclerosis
You're invited to TSF's Research Update & Award Ceremony in BCN 🇪🇸 during @ECTRIMS.
Join us for research updates, recognition of outstanding achievements in the field & networking with a community dedicated to neuroscience.
To reserve tickets, visit https://t.co/6ptUBrB1aW
This new multicentre study of 113 MOGAD patients looked at impact of disease burden on cognition longitudinally. One in 10 patients (11%) showed neuropsychological deficits, which were predicted stronlgly by cerebral lesions
https://t.co/GQr7t5GZ0W @NeuroVisionLab, @pia_sperber
🇨🇳 TSF was proud to participate in DUOSHEN's China #MS, #NMOSD, #MOGAD Patient Day in Beijing joined by 150 patients, caregivers and clinicians from all over China.
Sumaira, Michael Levy & Joachim Havla were international guest speakers at this milestone event.
去发光, 去照亮
What an informative week in Copenhagen #ECTRIMS2024@ECTRIMS with so many exciting new topics, so many wonderful colleagues + an incredibly great city where you can even go #skiing 🎿⛷️- I just had to do it 😍 Now I'm taking my luggage full of new ideas back home #ms
#MultipleSclerosis#PrognosticModels 👨💻 We have summarized the relevant points from our recent #CochraneReview here so that the use of prognostic models for therapy decisions in routine clinical practice can be successful in the future 👇 https://t.co/tus0Zq5gg1
This new multicentre study of 113 MOGAD patients looked at impact of disease burden on cognition longitudinally. One in 10 patients (11%) showed neuropsychological deficits, which were predicted stronlgly by cerebral lesions
https://t.co/GQr7t5GZ0W @NeuroVisionLab, @pia_sperber
1️⃣ month until TSF’s 7th Annual Gala at the National Aquarium Denmark 🪼🐠🦭🐡
If you’re attending ECTRIMS, join us on September 17th to illuminate #NMOSD & #MOGAD under the sea.
🎟️ Grab your tax-deductible tickets here: https://t.co/fVZMjo1Pwd
For this reason alone, it's worth attending this year's #ECTRIMS !
Sign up to support #NMOSD#MOGAD & celebrate with us!
And since you can/should dress in your country's formal attire👇 "Bavarian attendees" can show up in "dirndls & lederhosen" to match the #Oktoberfest season
🐟🪼🦈 Are you attending #ECTRIMS in Copenhagen? You're invited to attend TSF's 7th Annual Gala!
Illuminate #NMOSD & #MOGAD with us under the sea on Tuesday, Sep 17 at 7:00 PM at National Aquarium Denmark.
🎟️Reserve your tax-deductible tickets here: https://t.co/fVZMjo1Pwd
This new multicentre study of 113 MOGAD patients looked at impact of disease burden on cognition longitudinally. One in 10 patients (11%) showed neuropsychological deficits, which were predicted stronlgly by cerebral lesions
https://t.co/GQr7t5GZ0W @NeuroVisionLab, @pia_sperber
The chairs 🪑 are empty again, all participants have returned to the most beautiful corners of the world!!! 🌎🌍🌏Thank you to @guthyjacksonfdn for bringing us together again at the UCLA 🇺🇸 to discuss the international challenges of NMOSD and "beyond"!!! #NMOSD#snNMOSD
Extremely rare, but a key priority https://t.co/1OMxOR8myH! It's about cryopyrin-associated periodic syndromes (#CAPS) with CNS involvement 🧠 Overall, our study shows that #OCT 👁️🗨️ can be used as a marker of systemic inflammation! Dx and monitoring! https://t.co/W2WVrHaby4
Die #dmsg veranstaltet am 15.Juni 2024 wieder die wunderbare #MS Fachtagung 2024 in MÜNCHEN 🎤 Hier sind #PwMS und "Friends/Partners" eingeladen mitzudiskutieren und zu FRAGEN! Sprache: verständlich für Alle, keine Fachbegriffe! @LMU_Muenchen
Anmeldung: https://t.co/wz2EJRlqOX
My first time at ACTRIMS! It's wonderful, intensive and incredibly helpful for international exchange, both clinically and scientifically. The meetings can also be held in beautiful surroundings 🏝️☀️🇺🇸 #BREAKINGBARRIERSINMS but also in #NMOSD#MOGAD@ACTRIMS@INIM_Munich